This inventor holds 1 USPTO granted patent. Top assignee: Harvard College. Active years: 1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997
Title: The Innovations of Alexandru Cristian Bageac in Sickle Cell Treatment
Introduction
Alexandru Cristian Bageac, an innovative inventor located in Brookline, MA, has made significant strides in the medical field, particularly in the treatment of sickle cell disease. With a focus on detecting and managing vaso-occlusive crises, his contributions are paving the way for improved patient outcomes and advancements in therapeutic methods.
Latest Patents
Bageac holds a patent for "Methods of detecting and treating vaso-occlusive crisis in sickle cell". This innovative approach describes techniques for treating sickle cell disease, leveraging antibodies that competitively bind to suppress the adhesion of sickle erythrocytes to autologous lymphocytes. This breakthrough method provides a valuable resource for healthcare providers dealing with the complexities of sickle cell crises.
Career Highlights
Currently affiliated with Harvard College, Bageac's work exemplifies the intersection of academia and practical application in healthcare innovation. His dedication to enhancing patient care through scientific research illustrates the vital role that inventors play in medical advancements.
Collaborations
Throughout his career, Bageac has collaborated with notable figures in the research community, including David Eric Golan and Hemant Sadashiv Thatte. These partnerships not only enrich his innovative work but also contribute to a collaborative spirit that is often essential in research and development.
Conclusion
Alexandru Cristian Bageac’s contributions in the realm of sickle cell disease treatment reflect a commitment to improving medical practices through innovation. His patent illustrates the potential for new methodologies to enhance patient care, positioning him as a significant figure in the ongoing efforts to combat this challenging condition. As research continues, Bageac's work will likely inspire further advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
